TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RGNX

Regenxbio Inc

Healthcare · Biotechnology

7.40$ +2.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Regenxbio Inc (RGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 387 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RGNX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
634 574 629 569 519 466 491 581 525 453 342 387
366 335 395 347 313 278 313 374 332 281 187 236
53 35 113 58 57 58 130 80 59 34 15 36
302 275 339 290 255 235 268 323 274 230 150 106
32 26 17 24 25 22 19 21 26 27 11 107
13 – 0.0 – -13 – – – – – – –
271 262 239 221 218 206 217 367 364 350 321 315
127 130 110 98 103 103 107 120 125 118 71 83
6.6 7.1 46 39 7.7 7.9 7.9 8.0 51 48 7.9 7.4
22 23 31 16 20 23 19 22 22 21 21 16
363 312 391 348 301 260 274 214 161 103 21 72
-642 -705 -768 -821 -881 -932 -926 -997 -1,059 -1,126 -1,216 -1,193
44 44 46 51 51 51 51 51 52 52 52 53

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?